marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-14-2024
Spero Therapeutics Financial Ratios 2011-2024 | SPRO
Annual Financial Ratios Spero Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
3.8 | -1.1 | -4.1 | -4.2 | -2.9 | -3.7 | -0.8 | - | -4.9 | - | - | - | - |
P/S |
0.8 | 1.0 | 20.1 | 35.3 | 9.7 | 38.4 | 16.2 | - | - | - | - | - | - |
EPS |
0.4 | -1.2 | -2.9 | -3.5 | -3.4 | -2.6 | -17.8 | -95.9 | -53.1 | - | - | - | - |
EV (Enterprise Value) |
86.7 M | -7.24 M | 337 M | 265 M | 178 M | 131 M | -46.7 M | 7.41 M | 56.9 M | - | - | - | - |
EBITDA per Share |
0.41 | -1.1 | -2.83 | -4.31 | -3.44 | -2.65 | -16 | - | -0.971 | - | - | - | - |
EV/EBITDA |
-3.6 | -3.1 | -2.3 | -2.8 | 1.3 | - | -4.4 | - | - | - | - | ||
PEG |
-0.11 | 0.05 | - | 0.15 | 0.1 | -0.04 | 0.01 | - | 1.63 | - | - | - | - |
P/B |
0.8 | 0.7 | 4.2 | 2.5 | 2.4 | 1.3 | 0.4 | - | 252.4 | - | - | - | - |
P/CF |
-2.7 | -6.9 | -5.7 | -3.8 | -3.5 | -3.6 | -0.8 | - | -5.0 | - | - | - | - |
ROE % |
21.34 | -61.13 | -101.66 | -59.29 | -81.70 | -36.07 | -45.79 | - | -5180.61 | - | - | - | - |
ROA % |
12.50 | -37.19 | -52.47 | -51.01 | -57.42 | -32.29 | -41.45 | - | -141.50 | - | - | - | - |
ROCE % |
20.10 | -55.57 | -99.64 | -56.87 | -79.58 | -36.68 | -48.91 | - | -1742.12 | - | - | - | - |
Current Ratio |
2.4 | 2.6 | 2.1 | 9.7 | 3.6 | 10.1 | 11.3 | - | 0.9 | - | - | - | - |
DSO |
- | - | - | 241.6 | 171.9 | 119.5 | 542.8 | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Spero Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.32 | -0.33 | -0.24 | - | -0.06 | -0.23 | -0.25 | - | -0.33 | -0.87 | -1.01 | - | -0.7 | -0.63 | -0.66 | - | -0.86 | -0.85 | -1.22 | -1.31 | -0.95 | -0.74 | -0.29 | -0.6 | -0.6 | -0.69 | -0.74 | -1.59 | -36.02 | -36.21 | -21.6 | -25.68 | -23.23 | -25.3 | -21.51 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | - | - | - | - | -0.27 | - | -0.31 | -0.78 | -0.92 | - | -0.69 | -0.61 | -0.65 | - | -0.84 | -0.88 | -1.16 | - | -0.92 | -0.75 | -0.32 | - | -0.61 | -0.68 | -0.75 | - | -28.9 | -29.9 | -22.8 | - | -24.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-67.57 | -47.37 | -46.85 | -48.20 | -84.22 | -114.27 | -172.44 | -168.41 | -188.52 | -172.61 | -113.33 | -57.04 | -71.35 | -65.56 | -58.20 | -45.21 | -78.72 | -88.14 | -92.59 | -81.78 | -57.45 | -42.77 | -33.69 | -36.07 | -43.28 | -79.96 | -117.09 | -153.62 | -121.36 | -61.72 | -15.97 | 29.77 | 13.90 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-35.19 | -25.50 | -25.59 | -26.84 | -44.99 | -60.14 | -93.22 | -85.74 | -101.29 | -98.70 | -69.15 | -44.63 | -56.94 | -53.71 | -49.56 | -38.90 | -62.45 | -66.82 | -67.86 | -57.48 | -42.15 | -33.57 | -28.85 | -32.29 | -38.91 | -72.20 | -105.88 | -139.03 | -176.56 | -181.02 | -139.62 | -98.22 | -45.86 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-70.19 | -45.41 | -45.26 | -49.07 | -85.50 | -118.33 | -167.40 | -157.38 | -177.51 | -161.21 | -109.16 | -57.00 | -71.41 | -65.68 | -59.13 | -45.68 | -69.80 | -79.51 | -83.82 | -50.06 | -59.53 | -44.88 | -35.21 | -27.46 | -39.24 | -41.56 | -44.94 | -32.78 | -15.36 | 13.84 | 25.85 | 17.42 | 17.42 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
1.9 | 2.2 | 2.4 | 2.4 | 2.0 | 2.2 | 2.4 | 2.5 | 2.0 | 2.3 | 1.8 | 2.1 | 4.4 | 4.1 | 5.8 | 7.2 | 7.2 | 7.2 | 7.2 | 3.4 | 3.4 | 3.4 | 3.4 | 9.8 | 9.8 | 9.8 | 9.8 | 11.0 | 11.0 | 11.0 | 11.0 | 1.9 | 1.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency